South Texas Accelerated Research Therapeutics (START) Mountain Region — West Valley City, Utah

South Texas Accelerated Research Therapeutics (START) Mountain Region is a clinical research site located in West Valley City, Utah, United States 84119.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics (START) Mountain Region has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC), CCNE1 Amplified Advanced Solid Tumors.

Sponsors: NiKang Therapeutics, Inc., Monte Rosa Therapeutics, Inc, MacroGenics.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics (START) Mountain Region?

South Texas Accelerated Research Therapeutics (START) Mountain Region has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics (START) Mountain Region conducted?

South Texas Accelerated Research Therapeutics (START) Mountain Region has 3 clinical trials on record, with 3 currently active. Their work covers HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC), CCNE1 Amplified Advanced Solid Tumors.

Is South Texas Accelerated Research Therapeutics (START) Mountain Region accredited by Crixeo Health?

South Texas Accelerated Research Therapeutics (START) Mountain Region has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics (START) Mountain Region?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.